Clinical Trial Update: Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of paclitaxel poliglumex in combination with estradiol for Stage IV prostate cancer was terminated, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ESTRADIOL (Estradiol)
• Paclitaxel poliglumex (paclitaxel poliglumex)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2010-06-23